Hired and Retired: Controversies at the top
The new year has led to a new look to executive boards across the pharma industry, but the movement has arrived with a degree of intrigue in some cases.
A renowned scientist arrives at AstraZeneca, but only shortly after having to relinquish their previous position due to controversial non-disclosure of industry payments. Vertex also terminated the employment of a member of its C-suite on the grounds that their ‘personal behaviour’ was not sufficiently adequate to stay with the company.
Hired and Retired Alexander Hardy, Genentech Ian Smith, Vertex Jose Baselga, AstraZeneca Sean Bohen, AstraZeneca Philip Hampton, GSK